
Sign up to save your podcasts
Or


Double fellowship trained breast and women's health physician Dr. Sabrina Sahni returns this week to specifically discuss breast cancer risks with hormone therapy. Why the sudden change in recommendations after the Women's Health Initiative data, and what does that data really mean?
By Dabble Co.4.9
452452 ratings
Double fellowship trained breast and women's health physician Dr. Sabrina Sahni returns this week to specifically discuss breast cancer risks with hormone therapy. Why the sudden change in recommendations after the Women's Health Initiative data, and what does that data really mean?